A Study of Cadonilimab(AK104)Combined With Standard Treatment for Function Preservation in Urinary System Tumors
A Study of Cadonilimab(AK104)Combined With Standard Treatment for Function Preservation in Urinary System Tumors
Not yet recruiting · NCT06427057 · Registry updated 2024-05-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Cadonilimab(AK104)Combined With Standard Treatment for Function Preservation in Urinary System Tumors | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary system disorder, urinary system neoplasm | Not yet recruiting | Phase 2 | 2024-05-23 | NCT06427057 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tongji Hospital | 276 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||